Biomarkers and Silent Cardiac Disease in Primary Prevention

This publication has 10 references indexed in Scilit:

• Improving the Primary Prevention of Cardiovascular Events by Using Biomarkers to Identify Individuals With Silent Heart Disease
  JACC, 2012
• Meta-Analysis of B-Type Natriuretic Peptide's Ability to Identify Stress Induced Myocardial Ischemia
  The American Journal of Cardiology, 2011
• Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population
  JAMA, 2010
• Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom
  British Journal of Clinical Pharmacology, 2008
• Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study
  European Heart Journal, 2007
• Bedside Tests of B-Type Natriuretic Peptide in the Diagnosis of Left Ventricular Diastolic Dysfunction in Hypertensive Patients
  European Journal of Heart Failure, 2005
• Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
  New England Journal of Medicine, 2004
• Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography
  JACC, 2003
• Significance of silent ischemia andmicroalbuminuria in predicting coronaryevents in asymptomatic patients with type 2 diabetes
  JACC, 2002
• Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
  New England Journal of Medicine, 1992